{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T09:52:21Z","timestamp":1791971541726,"version":"4.3.4"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:00Z","timestamp":1766188800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Intensive Care"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.aicoj.2025.100022","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T17:12:29Z","timestamp":1768583549000},"page":"100022","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["High-dose versus standard-dose intermittent meropenem in critically ill patients: An observational cohort study"],"prefix":"10.1016","volume":"16","author":[{"given":"Felix","family":"Bergmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlene","family":"Prager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Pracher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Kumpf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Zeitlinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anselm","family":"Jorda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.aicoj.2025.100022_bib0005","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1001\/jama.2009.1754","article-title":"International study of the prevalence and outcomes of infection in intensive care units","volume":"302","author":"Vincent","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.aicoj.2025.100022_bib0010","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","article-title":"Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock","volume":"34","author":"Kumar","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1016\/j.aicoj.2025.100022_bib0015","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2147\/IDR.S343264","article-title":"Meropenem target attainment and population pharmacokinetics in critically ill septic patients with preserved or increased renal function","volume":"15","author":"Gijsen","year":"2022","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.aicoj.2025.100022_bib0020","doi-asserted-by":"crossref","DOI":"10.1186\/cc10441","article-title":"Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of \u03b2-lactams","volume":"15","author":"Gon\u00e7alves-Pereira","year":"2011","journal-title":"Crit Care Lond Engl."},{"key":"10.1016\/j.aicoj.2025.100022_bib0025","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/cid\/ciu027","article-title":"DALI: defining antibiotic levels in intensive care unit patients: are current \u03b2-lactam antibiotic doses sufficient for critically ill patients?","volume":"58","author":"Roberts","year":"2014","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.aicoj.2025.100022_bib0030","doi-asserted-by":"crossref","first-page":"1550053","DOI":"10.3389\/fmed.2025.1550053","article-title":"Optimization of meropenem dosing regimens in critically ill patients with augmented renal clearance","volume":"12","author":"Luo","year":"2025","journal-title":"Front Med"},{"key":"10.1016\/j.aicoj.2025.100022_bib0035","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/jac\/dkx330","article-title":"Maximally effective dosing regimens of meropenem in patients with septic shock","volume":"73","author":"Sj\u00f6vall","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.aicoj.2025.100022_bib0040","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciae403","article-title":"Infectious Diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections","author":"Tamma","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.aicoj.2025.100022_bib0045","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cmi.2021.11.025","article-title":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European Society of intensive care medicine)","volume":"28","author":"Paul","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.aicoj.2025.100022_bib0050","series-title":"Summary of Product Characterisitcs: Meropenem Kabi 1 g-Pulver zur Herstellung einer Injektions- bzw","author":"Kabi","year":"2022"},{"key":"10.1016\/j.aicoj.2025.100022_bib0055","doi-asserted-by":"crossref","first-page":"274","DOI":"10.2174\/1871526520666200227102013","article-title":"Clinical effectiveness of a high dose versus the standard dose of meropenem in ventilator-associated pneumonia caused by multidrugresistant bacteria: a randomized, single-blind clinical trial","volume":"21","author":"Monajati","year":"2021","journal-title":"Infect Disord Drug Targets"},{"key":"10.1016\/j.aicoj.2025.100022_bib0060","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40560-020-00442-7","article-title":"Clinical outcomes of empirical high-dose meropenem in critically ill patients with sepsis and septic shock: a randomized controlled trial","volume":"8","author":"Lertwattanachai","year":"2020","journal-title":"J Intensive Care"},{"key":"10.1016\/j.aicoj.2025.100022_bib0065","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/ejhpharm-2022-003535","article-title":"Meropenem population pharmacokinetics and model-based dosing optimisation in patients with serious bacterial infection","volume":"31","author":"Mur\u00ednov\u00e1","year":"2024","journal-title":"Eur J Hosp Pharm Sci Pract."},{"key":"10.1016\/j.aicoj.2025.100022_bib0070","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1128\/AAC.04166-14","article-title":"Population pharmacokinetics and Monte Carlo dosing simulations of meropenem during the early phase of severe sepsis and septic shock in critically ill patients in intensive care units","volume":"59","author":"Mur\u00ednov\u00e1","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.aicoj.2025.100022_bib0075","first-page":"2526","article-title":"Acute respiratory distress syndrome: the Berlin definition","volume":"307","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.aicoj.2025.100022_bib0080","first-page":"268","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis"},{"key":"10.1016\/j.aicoj.2025.100022_bib0085","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"issue":"Suppl 1","key":"10.1016\/j.aicoj.2025.100022_bib0090","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1086\/590064","article-title":"Pharmacokinetic and pharmacodynamic properties of meropenem","volume":"47","author":"Nicolau","year":"2008","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"8","key":"10.1016\/j.aicoj.2025.100022_bib0095","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s00134-021-06454-7","article-title":"Acute kidney injury in the critically ill: an updated review on pathophysiology and management","volume":"47","author":"Pickkers","year":"2021","journal-title":"Intensive Care Med"}],"container-title":["Annals of Intensive Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582025020369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582025020369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T09:24:30Z","timestamp":1791969870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2110582025020369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":19,"alternative-id":["S2110582025020369"],"URL":"https:\/\/doi.org\/10.1016\/j.aicoj.2025.100022","relation":{},"ISSN":["2110-5820"],"issn-type":[{"value":"2110-5820","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-dose versus standard-dose intermittent meropenem in critically ill patients: An observational cohort study","name":"articletitle","label":"Article Title"},{"value":"Annals of Intensive Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aicoj.2025.100022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 de R\u00e9animation de Langue Fran\u00e7aise (French Intensive Care Society).","name":"copyright","label":"Copyright"}],"article-number":"100022"}}